retatrutide for autoimmune disease Triple hormone receptor agonist metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide: Fat Loss, Liver Health
Description
GLP-1 medications work in part by slowing down stomach emptying, leading to increased feelings of fullness
January 13, 2026
Dysregulation of cytokine production, increased vulnerability to viral infections, autoimmune disorders, malnutrition, and inflammatory reactions are all linked to leptin deficiency/resistance [15]
3.4 Complications and side effects of GLP-1 RAs Common side effects associated with GLP-1 receptor agonists (GLP-1 RAs) include gastrointestinal symptoms such as nausea (2560%), diarrhea, and vomiting (515%) (46)
Obesity-related glomerulopathy: an emerging epidemic
